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Following publication of the original article (Machowska et al. [@CR1]), the authors provided new footnotes for Table [1](#Tab1){ref-type="table"} and Table [2](#Tab2){ref-type="table"}. The complete tables and updated footnotes are supplied below. Table 1Inpatients' characteristics at surgery departments of the TH and NTH in Madhya Pradesh, IndiaAll patientsUUTSILUTSIRASIEASITH,NTH,TH,NTH,TH,NTH,TH,NTH,TH,NTH,*N* = 6171*N* = 6263*N* = 284*N* = 741*N* = 748*N* = 824*N* = 1394*N* = 748*N* = 482*N* = 763*n* (%)*n* (%)*n* (%)*n* (%)*n* (%)*n* (%)*n* (%)*n* (%)*n* (%)*n* (%)Age in years 0--17*677 (11)* ^a^377 (6)21 (7)36 (5)*45 (6)* ^a^15 (2)*139 (10)* ^a^26 (3)72 (15)91 (12) 18--392018 (33)*2757 (44)* ^a^159 (56)425 (57)69 (9)119 (14)320 (23)*281 (38)* ^a^239 (50)419 (55) 40--591773 (29)1689 (27)78 (27)197 (27)150 (20)148 (18)453 (32)222 (30)108 (22)188 (25) ≥ 60*1703 (28)* ^a^1440 (23)26 (9)83 (11)484 (65)542 (66)482 (35)219 (29)63 (13)65 (8)Male*4601 (75)* ^a^4384 (70)218 (77)546 (74)719 (96)812 (99)*1182 (85)* ^a^532 (71)347 (72)610 (80)Female1570 (25)*1879 (30)* ^a^66 (23)195 (26)29 (4)12 (1)212 (15)*216 (29)* ^a^135 (28)153 (20)Patients prescribed AB5430 (88)5402 (86)251 (88)624 (84)748 (100)823 (100)*1393 (100)* ^a^628 (84)*482 (100)* ^a^719 (94)Total number of AB prescriptions (Np)12,21395985631055162414532767124014351679Prescriptions adherent to WHOLEM, Np (percentage of total nr. of prescriptions)*8039 (66)* ^a^4019 (42)*309 (55)* ^a^346 (33)*753 (46)* ^a^346 (24)*1736 (63)* ^a^510 (41)*1054 (73)* ^a^790 (47)Prescriptions adherent to NLEMI, Np (percentage of total nr. of prescriptions)*9119 (75)* ^a^5487 (57)342 (61)592 (56)*880 (54)* ^a^592 (41)*2025 (73)* ^a^734 (59)*1173 (82)* ^a^984 (59)Average length of hospital stay, days \[SD\]*9.9 \[10.0\]* ^a^4.6 \[3.9\]*9.1 \[7.8\]* ^a^3.8 \[3.2\]*13.0 \[11.3\]* ^a^5.0 \[3.2\]*9.8 \[7.2\]* ^a^5.1 \[4.0\]*11.1 \[9.5\]* ^a^6.3 \[5.3\]Average length of AB treatment, days \[SD\]*9.5 \[7.6\]* ^a^4.4 \[3.2\]*8.6 \[6.9\]* ^a^3.6 \[2.6\]*11.5 \[9.0\]* ^a^4.9 \[3.0\]*7.8 \[5.3\]* ^a^4.4 \[3.4\]*9.0 \[7.4\]* ^a^5.5 \[4.0\]AB prescribed for 1 day36 (1)221 (7)7 (2)96 (13)6 (1)44 (5)14 (1)41 (5)9 (2)40 (5)DDD/100 patient days72.5*110.5* ^a^89.5*112.3* ^a^84.6*102.1* ^a^78.3*116.1* ^a^74.9*106.0* ^a^Total nr. of AB doses administered65,28828,600275929509415473313,890406062707980Total nr. of AB doses prescribed using generic names*16,322 (25)* ^a^1716 (6)*607 (22)* ^a^118 (4)*2542 (27)* ^a^142 (3)*4584 (33)* ^a^203 (5)*1693 (27)* ^a^399 (5)Total nr. of AB doses administered parenterally34,613 (53)*19,639 (79)* ^a^1335 (41)*2245 (76)* ^a^3672 (39)*2603 (55)* ^a^8195 (59)*3370 (83)* ^a^4582 (75)*7339 (92)* ^a^Percentages were rounded off to integers, and standard deviations were rounded off to one decimal. Percentages are presented in parenthesis and standard deviations in square brackets. Significantly larger values are presented in italics*Abbreviations*: *AB* antibiotic, *DDD* defined daily dose, *EASI* emergency abdominal surgery indications, *Np* total number of antibiotic prescriptions, *nr.* number, *LUTSI* lower urinary tract surgery indications, *NLEMI* National List of Essential Medicines of India, *NTH* non-teaching hospital, *RASI* routine abdominal surgery indications, *SD* standard deviation, *TH* teaching hospital, *UUTSI* upper urinary tract surgery indications, *WHOLEM* WHO List of Essential Medicines^a^ Significant *p*-values Table 2Classification of surgery inpatients in four selected diagnoses groups, based on their diagnosesDiagnosis groups (ICD-10 codes)TH, *n* = 2908 (100)\
*n* (%) \[%\]NTH, *n* = 3076 (100)\
*n* (%) \[%\]Upper urinary tract surgery indications (UUTSI)284 (10) \[100\]*741 (24) \[100\]* ^a^ Kidney/ureter calculi (N20)280 \[99\]*734 \[99\]* ^a^ Other4 \[32\]7 \[1\]Lower urinary tract surgery indications (LUTSI)748 (26) \[100\]824 (27) \[100\] Benign prostate hyperplasia (N40)522 \[70\]558 \[68\] Urethral/bladder calculi (N21)89 \[12\]*142 \[17\]* ^a^ Urethral stricture (N35)85 \[11\]66 \[8\] Prostate cancer (C61)29 \[4\]30 \[4\] Bladder cancer (C67)10 \[1\]10 \[1\] Urethral disease^\*^ (N36)9 \[1\]10 \[1\] Other4 \[\<  1\]8 \[\<  1\]Routine abdominal surgery indications (RASI)*1394 (48) \[100\]* ^a^748 (24) \[100\] Hernia (K40-K46)*965 \[69\]* ^a^312 \[42\] Other gastric/duodenal disease (K31)113 \[8\]151 \[20\] Biliary calculi (K80)73 \[5\]110 \[15\] Anal fissure/fistula (K60)*103 \[7\]* ^a^30 \[4\] Malignancy in GI-tract (C15-C26)78 \[6\]51 \[7\] Cholecystitis (K81)30 \[2\]43 \[6\] Anal abscess (K61)10 \[\<  1\]28 \[4\] Other disease in anal region^\*\*^ (K62)10 \[\<  1\]8 \[1\] Colon polyposis (K63.2)9 \[\<  1\]5 \[\<  1\] Other3 \[\<  1\]10 \[\<  1\]Emergency abdominal surgery indications (EASI)482 (17) \[100\]*763 (25) \[100\]* ^a^ Appendicitis (K35-K37)268 \[56\]*459 \[60\]* ^a^ Intestinal obstruction (K56)132 \[27\]202 \[27\] Peritonitis (K56)80 \[17\]99 \[13\] Other2 \[\<  1\]3 \[\<  1\]Numbers of patients with percentages rounded off to the nearest whole number*Abbreviations: TH* teaching hospital, *NTH* non-teaching hospital^*\**^Urethral disease includes fistulas, diverticulosis, carbuncles, and prolepses of the urethra^\*\*^Disease in the anal/rectal region includes polyps, stenosis, wounds, bleedings, and prolapses in the anal/rectal region^a^ Significant *p*-values
